Prognosis and therapy control of colorectal cancer, useful e.g. for deciding on chemotherapeutic adjuvant treatment, by measuring amount of sialyl-Lewis antigen x

摘要

Prognosis and/or therapy control in cases of colorectal cancer, comprising determining the sialyl-Lewis x antigen (Ag), is new. An independent claim is also included for use of monoclonal antibody AM3 for use in the new process.